Article
Using explainable artificial intelligence to identify linguistic biomarkers of amyloid pathology in primary progressive aphasia
2024-05-05
Abstract excerpt
<h4>Introduction</h4> Recent success has been achieved in Alzheimer’s disease (AD) clinical trials targeting amyloid beta (β), demonstrating a reduction in the rate of cognitive decline. However, testing methods for amyloid-β positivity are currently costly or invasive, motivating the development of accessible screening approaches to steer patients toward appropriate diagnostic tests. Here, we employ a pre-trained...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- b9514553-ce8a-5b78-bd63-d7768b0a8a9d
- DOI
- 10.1101/2024.05.02.24306657
